Myocardial Infarction With Nonobstructive Coronary Arteries
9
2
3
1
Key Insights
Highlights
Success Rate
50% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 75/100
11.1%
1 terminated out of 9 trials
50.0%
-36.5% vs benchmark
22%
2 trials in Phase 3/4
0%
0 of 1 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (9)
Stratified Medicine of Eplerenone in Acute Myocardial Infarction or Injury and no Obstructive Coronary Arteries.
Stockholm Myocardial Infarction with Nonobstructive Coronaries Study 3
Prognostic Value of Precision Medicine in Patients With MINOCA (PROMISE Trial).
CMR in Myocardial Infarction with Nonobstructive Coronary Arteries
Randomized Evaluation of Beta Blocker and ACEI/ARB Treatment in MINOCA Patients - MINOCA-BAT
Cardiac Shock Wave Therapy for the Treatment of Myocardial Infarction With Non-obstructive Coronary Arteries
Rapid Identification of MINOCA Based on Novel Biomarkers
The Prognostic Role of Indices of Sympathetic Nervous System Overdrive in MINOCA
Etiologic Mechanisms, Myocardial Changes and Prognosis of Patients With MINOCA